Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for IMMUNE GLOBULIN INFUSION (HUMAN)
- Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
- A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants
- Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
- Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)
- Omental Islet Transplant
- Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
- CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma
- Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
- Hematopoietic Stem Cell Transplant for Sickle Cell Disease
- Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
- Multi-Drug Desensitization Protocol for Heart Transplant Candidates
- Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
- Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells
- Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
- Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
- Infusion of Expanded Cord Blood T Cells
- Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
- Hematopoietic Stem Cell Transplant in Devic's Disease
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
- Rituximab for GVHD
- Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
- Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
- Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
- Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
- Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
- Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
- A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
- Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
- Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients
- Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
- Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
- Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
- Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer
- Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Metastatic Breast Cancer
- Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
- Prevention of Recurrent Hepatitis B After Liver Transplantation
- Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS
- Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma
- Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection
- Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
- Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
- Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
- Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Clinical trials list
click for details